Ten-year survivors with multiple myeloma.
Of 130 Japanese patients with symptomatic multiple myeloma who were treated between 1970 and 1989, nine (6.9%) patients survived for more than 10 years. Younger age, low and intermediate tumour mass, chemotherapy with cyclophosphamide, the disappearance of myeloma protein, and a positive response to retreatment were correlated with long-term survival.
Murakami
H
H
Third Department of Internal Medicine, Gunma University School of Medicine, Japan.
Nemoto
K
K
Miyawaki
S
S
Shinonome
S
S
Nogiwa
E
E
Shimano
S
S
Sato
S
S
Omine
M
M
Naruse
T
T
Tsuchiya
J
J
D000368:Aged; D005260:Female; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy / Q000401:mortality*; D011379:Prognosis; D015996:Survival Rate